CELC

Celcuity is a biotechnology company developing a cancer drug called Gedatolisib. The drug is designed to treat certain types of breast cancer and prostate cancer by blocking proteins that help cancer cells grow. Celcuity licensed the drug from Pfizer and is currently testing it in patients. The company was founded in 2011 and is based in Minneapolis.